膠質(zhì)瘤化療現(xiàn)狀與展望
發(fā)布時間:2018-04-27 15:35
本文選題:膠質(zhì)瘤細(xì)胞 + 惡性膠質(zhì)瘤; 參考:《廣東醫(yī)學(xué)》2017年01期
【摘要】:正神經(jīng)膠質(zhì)瘤是中樞神經(jīng)系統(tǒng)最常見原發(fā)性腫瘤,占顱內(nèi)腫瘤的40%以上。在15歲以下兒童和15~34歲成年人群的癌癥死亡患者中,腦膠質(zhì)瘤是第二大原因。腦膠質(zhì)瘤,特別是高級別膠質(zhì)瘤(WHO分類Ⅲ~Ⅳ級腫瘤,也稱惡性膠質(zhì)瘤)發(fā)病多在青壯年,治療困難,預(yù)后差。目前,惡性膠質(zhì)瘤
[Abstract]:Positive glioma is the most common primary tumor in the central nervous system, accounting for more than 40% of intracranial tumors. Gliomas are the second leading cause of cancer deaths among children under 15 and adults aged 15-34. Brain gliomas, especially high-grade gliomas, are classified by WHO as grade 鈪,
本文編號:1811298
本文鏈接:http://sikaile.net/yixuelunwen/zlx/1811298.html
最近更新
教材專著